218 related articles for article (PubMed ID: 14653582)
21. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
Busch TM; Xing X; Yu G; Yodh A; Wileyto EP; Wang HW; Durduran T; Zhu TC; Wang KK
Photochem Photobiol Sci; 2009 Dec; 8(12):1683-93. PubMed ID: 20024165
[TBL] [Abstract][Full Text] [Related]
22. High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
Lapointe D; Brasseur N; Cadorette J; La Madeleine C; Rodrigue S; van Lier JE; Lecomte R
J Nucl Med; 1999 May; 40(5):876-82. PubMed ID: 10319764
[TBL] [Abstract][Full Text] [Related]
23. Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer.
Shafirstein G; Bellnier DA; Oakley E; Hamilton S; Habitzruther M; Tworek L; Hutson A; Spernyak JA; Sexton S; Curtin L; Turowski SG; Arshad H; Henderson B
Br J Cancer; 2018 Nov; 119(10):1191-1199. PubMed ID: 30353043
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy.
Karotki A; Khurana M; Lepock JR; Wilson BC
Photochem Photobiol; 2006; 82(2):443-52. PubMed ID: 16613497
[TBL] [Abstract][Full Text] [Related]
25. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
26. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
[TBL] [Abstract][Full Text] [Related]
28. Tolyporphin: a natural product from cyanobacteria with potent photosensitizing activity against tumor cells in vitro and in vivo.
Morlière P; Mazière JC; Santus R; Smith CD; Prinsep MR; Stobbe CC; Fenning MC; Golberg JL; Chapman JD
Cancer Res; 1998 Aug; 58(16):3571-8. PubMed ID: 9721863
[TBL] [Abstract][Full Text] [Related]
29. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
30. Tumor specific response to photodynamic therapy.
Stern SJ; Craig J; Flock S; Montague D; Waner M; Jacques S
Lasers Surg Med; 1993; 13(4):434-9. PubMed ID: 8366743
[TBL] [Abstract][Full Text] [Related]
31. Enzyme-activatable imaging probe reveals enhanced neutrophil elastase activity in tumors following photodynamic therapy.
Mitra S; Modi KD; Foster TH
J Biomed Opt; 2013 Oct; 18(10):101314. PubMed ID: 23897439
[TBL] [Abstract][Full Text] [Related]
32. Increasing the efficiency of photodynamic therapy by improved light delivery and oxygen supply using an anticoagulant in a solid tumor model.
Yang L; Wei Y; Xing D; Chen Q
Lasers Surg Med; 2010 Sep; 42(7):671-9. PubMed ID: 20740620
[TBL] [Abstract][Full Text] [Related]
33. Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model.
Li LB; Luo RC
Lasers Med Sci; 2009 Jul; 24(4):597-603. PubMed ID: 18936869
[TBL] [Abstract][Full Text] [Related]
34. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
Fingar VH; Mang TS; Henderson BW
Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
[TBL] [Abstract][Full Text] [Related]
35. Phototherapy and malignancy: possible enhancement by iron administration and hyperbaric oxygen.
Al-Waili NS; Butler GJ
Med Hypotheses; 2006; 67(5):1148-58. PubMed ID: 16860490
[TBL] [Abstract][Full Text] [Related]
36. Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.
Veenhuizen RB; Marijnissen JP; Kenemans P; Ruevekamp-Helmers MC; 't Mannetje LW; Helmerhorst TJ; Stewart FA
Br J Cancer; 1996 Jun; 73(11):1387-92. PubMed ID: 8645584
[TBL] [Abstract][Full Text] [Related]
37. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
[TBL] [Abstract][Full Text] [Related]
38. Photofrin
Baran TM
Lasers Surg Med; 2018 Jul; 50(5):476-482. PubMed ID: 29214668
[TBL] [Abstract][Full Text] [Related]
39. Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin.
Margaron P; Madarnas P; Quellet R; Van Lier JE
Anticancer Res; 1996; 16(2):613-20. PubMed ID: 8687105
[TBL] [Abstract][Full Text] [Related]
40. Combination with genistein enhances the efficacy of photodynamic therapy against human anaplastic thyroid cancer cells.
Ahn JC; Biswas R; Chung PS
Lasers Surg Med; 2012 Dec; 44(10):840-9. PubMed ID: 23143780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]